HIGHFDA DRUG
Accord Healthcare Recalls Levothyroxine Sodium Tablets Over Potency Issues
Accord Healthcare recalled 54,432 bottles of Levothyroxine Sodium Tablets on September 16, 2025. The tablets were found to be subpotent during stability testing. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Levothyroxine Sodium
Subpotent: During